Skip to content

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for Opioid Use Disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06157840
Enrollment
40
Registered
2023-12-06
Start date
2025-08-25
Completion date
2026-09-30
Last updated
2026-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid Use Disorder, Poor Quality Sleep

Brief summary

This study is to develop and test a medical health application based on cognitive behavioral therapy for insomnia and augmented with other evidence-based sleep interventions that address common sleep-related problems in opioid use disorder. An initial program will be built utilizing input from persons beginning medications for opioid use disorders.

Detailed description

This pilot randomized controlled trial will assess the feasibility and acceptability of an evidence-based behavioral sleep intervention delivered via a mHealth app to individuals initiating treatment with medications for opioid use disorder. Additional outcomes include changes in sleep disturbance over the course of the 6-week intervention. Participants (N=40, 20 per group) will be randomized to download the mHealth app to their smartphones and complete the intervention within 6 weeks. The control group will receive a simplified version of the app with sleep hygiene instructions. Both groups will complete daily electronic sleep diaries for the following 6 weeks. Each week, they will be asked to complete a short assessment of their experiences from the previous week and their current insomnia severity. At the end of the 6th week, they will complete an online series of questionnaires, including validated feasibility/acceptability measures and measures of insomnia severity.

Interventions

DEVICEmHealth application and sleep health education

Study participants will download the mHealth app to their smartphones and complete the intervention within 6 weeks. They will be required to complete daily electronic sleep diaries for the following 6 weeks. Each week, they will be asked to complete a short assessment of their experiences from the previous week and their current insomnia severity

DEVICESimplified mHealth application and sleep health education

Study participants will download the mHealth app to their smartphones and complete the intervention within 6 weeks. They will receive a simplified version of the app with sleep hygiene instructions and will be required to complete daily electronic sleep diaries for the following 6 weeks. Each week, they will be asked to complete a short assessment of their experiences from the previous week and their current insomnia severity.

Sponsors

Medical University of South Carolina
Lead SponsorOTHER
National Institute on Drug Abuse (NIDA)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* No experience of withdrawal symptoms in past 2 weeks * Being stabilized on buprenorphine 1. Initiated buprenorphine in past 3 months 2. Modified buprenorphine dose in past 3 months (e.g., reducing dose with goal of transitioning to vivitrol) * Currently experiencing clinically significant sleep disturbance (PSQI \> 5) * Able to read and understand English * Owns an Android or iOS smartphone * At least 18 years of age

Exclusion criteria

* Current psychotic symptoms * Current active suicidal ideation * Severe visual impairment * Current use of benzodiazepines * Current severe SUD other than OUD (i.e., \> 5 criteria met for any other SUD type per DSM-5) * Peripartum women

Design outcomes

Primary

MeasureTime frameDescription
Enrollment feasibility/acceptability benchmark of at least 30 persons completing entire study period - Enrollment and retention percentages6 weeks following enrollmentTo achieve a minimum enrollment and retention percentage of 75% throughout the 6-week investigation period.
Protocol adherence feasibility/acceptability benchmarks of participants completing modules and sleep diaries each week - Engagement6 weeks following enrollmentCompleting at least one module per week, submitting a minimum of four sleep diaries per week, and implementing stimulus control and sleep restriction on at least 90% of nights.
mHealth App Usability Questionnaire6 weeks following enrollmentValidated measure of mobile app usability with 3 sections: Ease of use/satisfaction, system information arrangement, and usefulness

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Quality IndexAt enrollment and 6 weeks following enrollmentValidated measure of difficulty falling and staying asleep and subsequent daytime function
Structured Clinical Interview for Sleep Disorders - Revised EditionAt enrollment and 6 weeks following enrollmentAssessment for sleep disorders based on the DSM-5
Insomnia Severity IndexAt enrollment and 6 weeks following enrollmentGlobal sleep quality; the most common self-reported sleep measure
Daily Sleep Diary - Sleep Onset LatencyThrough study completion of 6 weeksSubjective sleep onset latency (time to fall asleep)
Daily Sleep Diary - Wake-time After SleepThrough study completion of 6 weeksSubjective time awake after sleep onset
Daily Sleep Diary - Total Sleep TimeThrough study completion of 6 weeksSubjective total sleep time
Daily Sleep Diary - Sleep EfficiencyThrough study completion of 6 weeksSubjective sleep efficiency

Countries

United States

Contacts

CONTACTAllison K Willkerson, Ph.D.
wilkersa@musc.edu843-792-4636
CONTACTJacelyn Lane
lanejac@musc.edu
PRINCIPAL_INVESTIGATORAllison K Wilkerson, Ph.D.

Medical University of South Carolina

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 13, 2026